HAI
CRL icon

Hennessy Advisors Inc’s Charles River Laboratories CRL Stock Holding History

Hennessy Advisors Inc’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-118,700
Closed -$9.89M – 283
2016
Q3 		$9.89M Buy
+118,700
New +$9.95M 0.28% 87

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Hennessy Advisors Inc's CRL Position: Q4 2016 in Review

Hennessy Advisors Inc sold out of Charles River Laboratories (CRL) in Q4 2016, closing a stake of 118,700 shares — an estimated $9.89M sold.

Hennessy Advisors Inc first reported a position in CRL in Q3 2016 and held it in 1 quarter. The position peaked at $9.89M in Q3 2016. 297 funds tracked by Wall St. Rank hold CRL as of Q4 2016.

  • Hennessy Advisors Inc reported no remaining Charles River Laboratories position as of Q4 2016 after selling out during the quarter.
  • Hennessy Advisors Inc sold 118,700 Charles River Laboratories shares in Q4 2016, an estimated $9.89M.
  • Hennessy Advisors Inc first reported a position in Charles River Laboratories in Q3 2016 and held it in 1 quarter.
  • Hennessy Advisors Inc's Charles River Laboratories position peaked at $9.89M in Q3 2016.
  • 297 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2016.

Based on Hennessy Advisors Inc's 13F filing for Q4 2016, filed 17 Jan 2017.